首页> 外国专利> Benzofuryl-alpha-pyrone derivative, pharmaceutical composition, lipid metabolism enhancer, triglyceride biosynthesis inhibitor, blood triglyceride reducing agent, blood hdl elevating agent, prophylactic agent for arteriosclerosis, and, treatment agent for arteriosclerosis

Benzofuryl-alpha-pyrone derivative, pharmaceutical composition, lipid metabolism enhancer, triglyceride biosynthesis inhibitor, blood triglyceride reducing agent, blood hdl elevating agent, prophylactic agent for arteriosclerosis, and, treatment agent for arteriosclerosis

机译:苯并呋喃基-α-吡喃酮衍生物,药物组合物,脂质代谢增强剂,甘油三酸酯生物合成抑制剂,血液甘油三酸酯减少剂,血液hdl升高剂,动脉硬化预防剂和动脉硬化治疗剂

摘要

"BENZOFURIL-ALFA-PIRONA DERIVED, PHARMACEUTICAL COMPOSITION, LIPID METABOLISM ENHANCER, BIOSYSTEM INHIBITOR OF TRIGLYCERIDES, BLOOD TRIGLYCERIDES AGENT, BLOOD AGENT, TREATMENT AGENT ARTERIOSCLEROSIS ". Benzofuryl- 244 -pyrone derivatives represented by the general formula (I) or their salts in which R¹ represents hydrogen or C ~ 1-2 ~ alkyl; R² represents hydrogen, -CO-R ^ 5 ^ or SO ~ 2 ~ R ^ 6 ^; R ^ 3 ^ represents hydrogen, C ~ 1-5 ~ alkyl, etc .; and R4 is a substituent with a defined structure attached at the 4, 5, 6 or 7 position of the benzofuran ring. These compounds are useful as drugs for hyperglyceridemia, lipid metabolism-improving agents, preventives / drugs for arteriosclerosis, etc.
机译:“衍生自苯甲醛-阿尔法-皮罗那,药物组合物,脂质代谢增强剂,甘油三酯的类固醇抑制剂,血液甘油三酯试剂,血液剂,治疗剂动脉硬化”。通式(Ⅰ)代表的苯并呋喃基-<244>-吡喃酮衍生物或其盐,其中R 1代表氢或C 1-2-烷基。 R 2代表氢,-CO-R ^ 5 ^或SO〜2〜R ^ 6 ^; R ^ 3 ^代表氢,C〜1-5〜烷基等; R4是在苯并呋喃环的4、5、6或7位上具有确定的结构的取代基。这些化合物可用作高血糖症药物,脂质代谢改善剂,动脉硬化的预防剂/药物等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号